The set-up: Axovant Sciences Ltd. is a clinical-stage biopharma company with a Phase III trial coming out in September for treatment for Alzheimer’s Disease.
Why others are buying it: The stock is up more than 80 percent this year, and it is nearing its all-time peak of $31 per share; it has some room to run to get back to that level, especially if people wind up getting the good news they’re expecting on this trial.
From a trader’s perspective, this is a jumpy stock, the kind of thing that moves a lot on news; catalyst traders like that when there is news on the horizon.
Why I’m not: With Alzheimer’s Disease, any time there is news people really speculate on the upside. If the trial comes out positive, it’s close to a double, a binary event, but 90 percent of the time with these types of drugs, the news doesn’t pan out and the stock trades way down; the downside potential is more than 50 percent.
I’m like everyone else in hoping that we someday see a cure, but I’m not getting too excited because it’s hard to believe the data is going to be good; the science for these Alzheimer’s drugs just hasn’t paid out.
Kyle Dennis runs Kyle Dennis’ Biotech Breakouts (biotechbreakouts.com). He is an event-based trader, who prefers low-priced and small-cap biotech stocks. He currently has no shares, options or open orders in AXON; he last owned the stock on June 7, when he played it as a day trade.
You may also like
Exclusive System Tracks Wall St. Insiders
“Dollar Ace Simply Exposes Information That Wall Street Wants To Keep Quiet” Said Kyle Dennis
“One member, Wesley M., has already reported 360%+ gains in just a few short days. Don’t miss this!”
(Reserve Access Now)
“What Recession?!” Jason Bond nets $55,060 in realized profit in One Day
After going 6 for 6 on profitable trades recently, we caught up with Jason to ask how he did it.
Check out Jason’s exclusive interview revealing this tightly guarded strategy. (Watch Now)
RagingBull.com Co-Founder, Jeff Bishop, Launches High Conviction Trade Service
“We listen to our clients and we give them EXACTLY what they want, so we designed a service to deliver 1 trade, 1 time a week, with a 100%+ PROFIT TARGET, directly to your inbox every Monday before the market opens. (Read More)